Market Closed

CNTX
Context Therapeutics
$ 0.1808
-8.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Context Therapeutics News

Latest Context Therapeutics Stock News & CNTX Headlines

Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress
4 days ago | globenewswire.com
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
2 months ago | globenewswire.com
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
3 months ago | globenewswire.com
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
4 months ago | globenewswire.com
Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Study
5 months ago | benzinga.com
Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
5 months ago | globenewswire.com
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 months ago | globenewswire.com
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
6 months ago | globenewswire.com
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
6 months ago | globenewswire.com
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CNTX
Context Therapeutics
$ 0.1808
-8.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago